Q1 EPS Forecast for Revolution Medicines Boosted by Analyst
Revolution Medicines, Inc. (NASDAQ:RVMD – Free Report) – Research analysts at Wedbush lifted their Q1 2025 earnings per share estimates for shares of Revolution Medicines in a note issued to investors on Wednesday, February 26th. Wedbush analyst R. Driscoll now forecasts that the company will post earnings per share of ($0.89) for the quarter, up […]
Revolution Medicines, Inc. (NASDAQ:RVMD – Free Report) – Research analysts at Wedbush lifted their Q1 2025 earnings per share estimates for shares of Revolution Medicines in a note issued to investors on Wednesday, February 26th. Wedbush analyst R. Driscoll now forecasts that the company will post earnings per share of ($0.89) for the quarter, up […]
